AzTrials
AzTrials

HealthyMAIZENCT02373943

The MULTINUTRIENT Maize Project: Results of Human Feeding Trial

A study testing β-carotene biofortified maize, β-carotene supplemented maize and Normal (non biofortified) maize without added β-carotene in people with Healthy, run by Institut de Recerca Biomèdica de Lleida at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The main objective of this human trial is the demonstration that β-carotene in fortified maize has good bioavailability as a plant source of vitamin A and that when humans ingest the biofortified product retinol levels are higher than when they ingest non biofortified white maize. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
β-carotene biofortified maize, β-carotene supplemented maize and Normal (non biofortified) maize without added β-carotene
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
20 participants
Where
1 siteSpain
Study dates
Sep 2015to Mar 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Healthy persons
  • Persons who had not taken vitamin A or β-carotene supplements within the past month

Who cannot join

  • Current or recent (previous 12 mo) cigarette smoking
  • Frequent consumption of alcoholic beverages (1 drink/d)
  • Current or recent (previous 1 mo) use of dietary supplements
  • Current or recent (previous 6 mo) use of hormonal contraceptives
  • Current or recent (previous 1 mo) use of medications known to affect lipid metabolism.
  • History of restrictive eating
Show all 17Show fewer
  • BMI under 20 or over 30
  • Lactose intolerance
  • Vegetarians.
  • Severe or symptomatic cardiac disease or hypertension
  • History of bleeding disorders
  • Chronic history of gastric, intestinal, liver, pancreatic, or renal disease
  • Any portion of the stomach or the intestine removed (other than an appendectomy)
  • History of intestinal obstruction, malabsorption, or use of antacid drugs; cancer (active or use of medications for a history of cancer treatment within the past 5 y)
  • History of chronic alcoholism
  • History of convulsive disorder
  • Evidence of active drug abuse

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Hospital Universitari Arnau de Vilanova

    Lleida, LLeida, 25110

Other trials in Spain

About this study

Official title: Bioavailability of Vitamin A From β-carotene-Biofortified Maize Porridge Consumed by Women and Men: Results of a Randomized Crossover Trial

The main objective of this human trial is the demonstration that β-carotene in fortified maize has good bioavailability as a plant source of vitamin A and that when humans ingest the biofortified product retinol levels are higher than when they ingest non biofortified white maize.

Read the detailed description

Human feeding trial with fortified maize is part of the BIOFORCE project which aims to create transgenic cereal plants that will provide a near complete micronutrient complement for malnourished people. β-Carotene intake helps to balance inadequate retinol supply in significant parts of the world. In order for plants with enhanced levels of micronutrients to be useful, the micronutrients must be present in a bioavailable form that can be absorbed by the human body. To test the main hypothesis of the trial an open-label, randomized, three-way crossover trial consisting of three 7-day feeding periods has been designed. The study will compare three different feeding conditions: β-carotene fortified maize containing diet, white maize containing diet supplemented with a reference β-carotene dose and white maize diet. The study will test the hypothesis that a meal including fortified maize yields superior all-trans retinol area under the plasma concentration versus time curve (AUC) values than an isocaloric and isoprotein meal with normal maize.

After a first screen that will address physical conditions and lifestyle 18 volunteers (9 men and 9 women) who meet the eligibility criteria will be included in the study once they have read and sign the informed consent. The postprandial plasma all-trans retinol response to each test meal will be used to establish the bioavailability of provitamin A from fortified maize. The test meals will be consumed in random order separated by 1 week. Blood samples will be collected over 8 h. All-trans retinol will be analyzed in plasma by high pressure liquid chromatography (HPLC) with coulometric array electrochemical detection.

Mean AUC for all-trans retinol in plasma after ingestion of the β-carotene-fortified maize porridge, the white maize porridge with the β-carotene reference dose, and the white maize porridge will be compared.

Conditions
Healthy
Being tested
β-carotene biofortified maize, β-carotene supplemented maize, Normal (non biofortified) maize without added β-carotene
Keywords
vitamin A, human, bioavailability, fortified maize, cross-over, beta-carotene

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • β-carotene biofortified maizeOther

    Determination of all-trans retinol AUC values after the ingestion of 200 g porridge made with 50 g of flour of β-carotene fortified maize

  • β-carotene supplemented maizeOther

    Determination of all-trans retinol AUC values after the ingestion of 200 g porridge made with 50 g of flour of β-carotene supplemented maize

  • Normal (non biofortified) maize without added β-caroteneOther

    Determination of all-trans retinol AUC values after the ingestion of 200 g porridge made with 50 g of flour of normal maize

Study groups in NCT02373943
Study groupRoleWhat they receive
β-carotene biofortified maizeExperimentalParticipants will ingest porridge bF: this will be the β-carotene fortified maize porridge where each 250 g will be made with 50 g of dry maize flour obtained from fortified corn seeds. The contents of β-carotene and other provitamin A carotenoids in this flour will be determined before preparing the porridges.
Receives: Other: β-carotene biofortified maize
white maize supplemented with β-caroteneActive comparatorParticipants will ingest porridge F: this will be also a β-carotene fortified maize porridge but in this case it will be made with 50 g of dry maize flour obtained from non fortified corn seeds and supplemented with a 500-1500 µg β-carotene reference dose. The exact dose of β-carotene that will be added to these porridges will be established according to the amount of β-carotene found in the flour used with porridges BF.
Receives: Other: β-carotene supplemented maize
white maizeSham comparatorParticipants will ingest porridge N which will be the control porridge and will be made with 50 g of dry maize flour obtained from non fortified corn seeds.
Receives: Other: Normal (non biofortified) maize without added β-carotene

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Comparison of vitamin A bioavailability, as measured by the plasma all-trans retinol response, between fortified maize and wild type

    Comparison of baseline corrected AUC plasma concentrations of all-trans retinol over 8h

    Measured: Pharmacokinetic measures: -15 min, 2h, 3.5h, 5h, 7h. 8h

Secondary outcomes (1)
  1. Relative bioavailability of provitamin A in terms of fortified maize vs wild type maize supplemented with a beta-carotene reference dose.

    Comparison of baseline corrected AUC plasma concentrations of all-trans retinol over 8h

    Measured: Pharmacokinetic measures: -15 min, 2h, 3.5h, 5h, 7h. 8h

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Feb 2015 (estimated)
  2. Study startSep 2015
  3. Primary completionMar 2016
  4. Study completionMar 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02373943
Sponsor's protocol ID
ERCEA - PoC2013 - 619161
Acronym
MAIZE
Status last verified
Mar 2016
First submitted
15 Feb 2015
Last updated
25 Mar 2016
Results posted
No
Data monitoring committee
No

Publications

  • Li S, Nugroho A, Rocheford T, White WS. Vitamin A equivalence of the ss-carotene in ss-carotene-biofortified maize porridge consumed by women. Am J Clin Nutr. 2010 Nov;92(5):1105-12. doi: 10.3945/ajcn.2010.29802. Epub 2010 Sep 1.

    PubMed 20810977
  • Grune T, Lietz G, Palou A, Ross AC, Stahl W, Tang G, Thurnham D, Yin SA, Biesalski HK. Beta-carotene is an important vitamin A source for humans. J Nutr. 2010 Dec;140(12):2268S-2285S. doi: 10.3945/jn.109.119024. Epub 2010 Oct 27.

    PubMed 20980645
  • Christou P, Twyman RM. The potential of genetically enhanced plants to address food insecurity. Nutr Res Rev. 2004 Jun;17(1):23-42. doi: 10.1079/NRR200373.

    PubMed 19079913
  • Paine JA, Shipton CA, Chaggar S, Howells RM, Kennedy MJ, Vernon G, Wright SY, Hinchliffe E, Adams JL, Silverstone AL, Drake R. Improving the nutritional value of Golden Rice through increased pro-vitamin A content. Nat Biotechnol. 2005 Apr;23(4):482-7. doi: 10.1038/nbt1082. Epub 2005 Mar 27.

    PubMed 15793573
  • Gannon B, Kaliwile C, Arscott SA, Schmaelzle S, Chileshe J, Kalungwana N, Mosonda M, Pixley K, Masi C, Tanumihardjo SA. Biofortified orange maize is as efficacious as a vitamin A supplement in Zambian children even in the presence of high liver reserves of vitamin A: a community-based, randomized placebo-controlled trial. Am J Clin Nutr. 2014 Dec;100(6):1541-50. doi: 10.3945/ajcn.114.087379. Epub 2014 Oct 8.

    PubMed 25411289

Questions about this trial

What is this clinical trial studying?

A study testing β-carotene biofortified maize, β-carotene supplemented maize and Normal (non biofortified) maize without added β-carotene in people with Healthy, run by Institut de Recerca Biomèdica de Lleida at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Mar 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Comparison of vitamin A bioavailability, as measured by the plasma all-trans retinol response, between fortified maize and wild type (time frame: Pharmacokinetic measures: -15 min, 2h, 3.5h, 5h, 7h. 8h). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02373943, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Mar 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in